SEC Filings

SEC Filings

Filing date	Description	Form	View
Mar 12, 2009	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001193125-09-052380.pdf 0001193125-09-052380.rtf 0001193125-09-052380.xls
Mar 10, 2009	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000080255-09-000517.pdf 0000080255-09-000517.rtf
Mar 10, 2009	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	View HTML 0001362310-09-003497.pdf 0001362310-09-003497.rtf 0001362310-09-003497.xls
Mar 09, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001181431-09-014305.pdf 0001181431-09-014305.rtf 0001181431-09-014305.xls
Mar 06, 2009	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	View HTML 0001362310-09-003342.pdf 0001362310-09-003342.rtf 0001362310-09-003342.xls
Mar 04, 2009	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	View HTML 0000950133-09-000574.pdf 0000950133-09-000574.rtf 0000950133-09-000574.xls
Feb 27, 2009		D	View HTML 0001181431-09-012123.pdf 0001181431-09-012123.rtf
Feb 25, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-011091.pdf 0001181431-09-011091.rtf
Feb 25, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-09-011092.pdf 0001181431-09-011092.rtf
Feb 25, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-09-011436.pdf 0001209191-09-011436.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE